# A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

> **NCT00866762** · PHASE2 · UNKNOWN · sponsor: **Copenhagen University Hospital at Herlev** · enrollment: 60 (estimated)

## Conditions studied

- Polycythemia Vera
- Essential Thrombocythemia

## Interventions

- **DRUG:** HDAC inhibitor (MK-0683)

## Key facts

- **NCT ID:** NCT00866762
- **Lead sponsor:** Copenhagen University Hospital at Herlev
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866762, "A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00866762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*